{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:45:12Z","timestamp":1759563912382},"publisher-location":"New York, NY","reference-count":26,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461590828"},{"type":"electronic","value":"9781461590804"}],"license":[{"start":{"date-parts":[[1978,1,1]],"date-time":"1978-01-01T00:00:00Z","timestamp":252460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1978]]},"DOI":"10.1007\/978-1-4615-9080-4_13","type":"book-chapter","created":{"date-parts":[[2012,6,7]],"date-time":"2012-06-07T01:00:48Z","timestamp":1339030848000},"page":"159-174","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Interferon Therapy for Neoplastic Diseases in Man In Vitro and In Vivo Studies"],"prefix":"10.1007","author":[{"given":"Stefan","family":"Einhorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Strander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,21]]},"reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1099\/0022-1317-28-2-207","volume":"28","author":"A Adams","year":"1975","unstructured":"Adams, A., H. Strander, and K. Cantell. 1975. Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon. J. Gen.Virol. 28: 207\u2013217.","journal-title":"J. Gen.Virol"},{"key":"13_CR2","unstructured":"Aparisi, T., L. A. Brostrom, S. Ingimarsson, C. Lagergren, U. Nilsonne, H. Strander, and G. Soderberg. 1977. Prognostic factors in osteosarcoma. Can historical controls be used in current clinical trials? Intern.J.Rad.Oncol.Biol. Phys., in press."},{"key":"13_CR3","first-page":"527","volume":"199","author":"H Blomgren","year":"1976","unstructured":"Blomgren, H., K. Cantell, B. Johansson, C. Lagergren, U. Ringborg, and H. Strander. 1976. Interferon therapy in Hodgkin\u2019s desease: Acta med.Scand. 199: 527\u2013532.","journal-title":"Interferon therapy in Hodgkins desease: Acta med.Scand"},{"key":"13_CR4","unstructured":"Cantell, K. 1977. Prospects for the clinical use of exogenous interferon. Med.Biol., in press."},{"key":"13_CR5","first-page":"35","volume-title":"The Production and Use of Interferon for the Treatment and Prevention of Human Virus Infections, Proceedings of a Tissue Culture Association Workshop","author":"K Cantell","year":"1974","unstructured":"Cantell, K., S. Hirvonen, K. E. Mogensen, and L. Pyhala. 1974. Human leukocyte interferon: production, purification, stability and animal experiments. In: C. Waymouth (Ed.), The Production and Use of Interferon for the Treatment and Prevention of Human Virus Infections, Proceedings of a Tissue Culture Association Workshop. Tissue Culture Association, Rockville, pp. 35\u201338."},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1099\/0022-1317-25-3-453","volume":"22","author":"K Cantell","year":"1974","unstructured":"Cantell, K., L. Pyhala, and H. Strander. 1974. Circulating human interferon after intramuscular injection into animals and man. J. Gen.Virol. 22: 453\u2013455.","journal-title":"J. Gen.Virol"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1099\/0022-1317-35-3-573","volume":"35","author":"S Einhorn","year":"1977","unstructured":"Einhorn, S., and H. Strander. 1977. Is interferon tissue specific? - Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines. J. Gen.Virol. 35: 573\u2013577.","journal-title":"J. Gen.Virol"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0065-230X(08)60339-5","volume":"16","author":"I. Gresser","year":"1972","unstructured":"Gresser, I. 1972. Antitumour effects of interferon. Adv. Cancer Res. 16: 97\u2013140.","journal-title":"Adv. Cancer Res."},{"key":"13_CR9","volume-title":"Cancer. A comprehensive treatise","author":"I Gresser","year":"1977","unstructured":"Gresser, I. 1977. Antitumour effects of interferon. In: F. Becker (ed.), Cancer. A comprehensive treatise, in press."},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/jnci\/52.2.553","volume":"52","author":"I Gresser","year":"1974","unstructured":"Gresser, I., M.T. Bandu, and D.Brouty-Boye. 1974. Interferon and cell division. IX. Interferon-resistant L1210 cells: characteristics and origin. J.Nat.Cancer Inst. 52: 553\u2013559.","journal-title":"J.Nat.Cancer Inst"},{"key":"13_CR11","first-page":"1145","volume":"45","author":"I Gresser","year":"1970","unstructured":"Gresser, I., D. Brouty-Boye, M. T. Thomas, and A. Macieira-Coelho. 1970. Interferon and cell division II. Influence of various experimental conditions on the inhibition of L1210 cell multiplication in vitro by interferon preparations. J.Nat.Cancer Inst. 45: 1145\u20131153.","journal-title":"J.Nat.Cancer Inst"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1073\/pnas.72.6.2185","volume":"72","author":"EA Havell","year":"1975","unstructured":"Havell, E. A., B. Berman, C. A. Ogburn, K. Berg, K. Paucker, and J. Vilcek. 1975. Two antigenically distinct species of human interferon. Proc.Nat.Ac.Sci.US 72: 2185\u20132187.","journal-title":"Proc.Nat.Ac.Sci.US"},{"key":"13_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1128\/AAC.2.6.476","volume":"2","author":"E. A. Havell","year":"1972","unstructured":"Havell, E. A., and J. Vilcek. 1972. Production of hightitred interferon in cultures of human diploid cells. Antimicrob. Ag. Chemother. 2: 476\u2013484.","journal-title":"Antimicrob. Ag. Chemother."},{"key":"13_CR14","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1128\/JVI.16.5.1124-1130.1975","volume":"16","author":"WJ Jankowski","year":"1975","unstructured":"Jankowski, W. J., M. W. Davey, J. A. O\u2019Malley, E. Sulkowski, and W. A. Carter. 1975. Molecular sturcture of human fibroblast and leukocyte interferons:probe by lectin and hydrophobic chromatography. J.Virol. 16: 1124\u20131130.","journal-title":"J.Virol"},{"key":"13_CR15","doi-asserted-by":"crossref","unstructured":"Mogensen, K. E. and K. Cantell. 1977. Production and preparation of human leukocyte interferon. Pharmacology and therapeutics, in press.","DOI":"10.1016\/0362-5478(77)90002-X"},{"key":"13_CR16","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/0042-6822(62)90123-X","volume":"17","author":"K Paucker","year":"1962","unstructured":"Paucker, K., K. Cantell, and W. Henle. 1962. Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cell. Virology 17: 324\u2013334.","journal-title":"Virology"},{"key":"13_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"R Peto","year":"1977","unstructured":"Peto, R., M.C. Pike, P. Armitage, N. E. Breslow, D. R. Cox, S. V. Howard, N. Mantel, K. McPherson, J. Peto, and P. G. Smith. 1977. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br.J.Cancer 35: 1\u201339.","journal-title":"Br.J.Cancer"},{"key":"13_CR18","unstructured":"Strander, H. 1977. Anti-tumour effects of interferon and its possible use as an anti-neoplastic agent in man. Texas Reports Biol.Med., in press."},{"key":"13_CR19","doi-asserted-by":"crossref","unstructured":"Strander, H. 1977. Interferons: Anti-neoplastic drugs? Blut, in press.","DOI":"10.1007\/BF00996140"},{"key":"13_CR20","first-page":"265","volume":"44","author":"H Strander","year":"1966","unstructured":"Strander, H., and K. Cantell. 1966. Production of interferon by human leukocytes in vitro. Ann.Med.Exp.Biol.Fenn. 44: 265\u2013273.","journal-title":"Ann.Med.Exp.Biol.Fenn"},{"key":"13_CR21","first-page":"49","volume-title":"The Production and Use of Interferon for the Treatment and Prevention of Human Virus Infections, Proceedings of a Tissue Culture Association Workshop","author":"H Strander","year":"1974","unstructured":"Strander, H., and K. Cantell. 1974. Studies on antiviral and antitumour effects of human leukcyte interferon iri vitro and in vivo. In: The C. Waymouth (Ed.), The Production and Use of Interferon for the Treatment and Prevention of Human Virus Infections, Proceedings of a Tissue Culture Association Workshop. Tissue Culture Association, Rockville, pp. 49\u201356."},{"key":"13_CR22","first-page":"377","volume-title":"Modulation of host immune resistance in the prevention or treatment of induced neoplasias","author":"H Strander","year":"1977","unstructured":"Strander, H., K. Cantell, S. Ingimarsson, P. A. Jakobsson, U. Nilsonne, and G. Soderberg. 1977. Interferon treatment of osteogenic sarcoma \u2014 a clinical trial. In: M. A. Chirigos (Ed.), Modulation of host immune resistance in the prevention or treatment of induced neoplasias, Dec. 9\u201311, 1974. Fogarty Int. Center Proc., US Government Printing Office, Washington DC, No. 28, pp. 377\u2013381."},{"key":"13_CR23","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/ijc.2910190406","volume":"19","author":"H Strander","year":"1977","unstructured":"Strander, H., and S. Einhorn. 1977. Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue culture. Int. J. Cancer 19: 468\u2013473.","journal-title":"Int. J. Cancer"},{"key":"13_CR24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1128\/JCM.1.1.116-117.1975","volume":"1","author":"H. Strander","year":"1975","unstructured":"Strander, H., K. E. Mogensen, and K. Cantell. 1975. Production of human lymphoblastoid interferon. J. clin. Microbiol. 1: 116\u2013117.","journal-title":"J. clin. Microbiol."},{"key":"13_CR25","first-page":"2","volume-title":"Symposium of interferons and the control of cell-virus interactions, Rehovot","author":"J Vilcek","year":"1977","unstructured":"Vilcek, J. 1977. Protein chemistry and molecular biology of interferons: a secular view. In: M. Revel, D. Gurari-Rotman, and E. Winoccour (Eds.), Symposium of interferons and the control of cell-virus interactions, Rehovot, Israel, May 2\u20136."},{"key":"13_CR26","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.4049\/jimmunol.111.6.1914","volume":"111","author":"JS Youngner","year":"1973","unstructured":"Youngner, J. S., and S. B. Salvin. 1973. Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed type hypersensitivity. J. Immunol. 111: 1914\u20131922.","journal-title":"J. Immunol"}],"container-title":["Advances in Experimental Medicine and Biology","Human Interferon"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-9080-4_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T05:23:59Z","timestamp":1687497839000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-9080-4_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978]]},"ISBN":["9781461590828","9781461590804"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-9080-4_13","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[1978]]},"assertion":[{"value":"21 January 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}